Editor-in-Chief Dr. Sue Yom hosts a discussion this month on the role of radiotherapy in the optimal treatment of recurrent and refractory lymphoma. Guests include Dr. Belinda Campbell, the journal’s Section Editor of lymphoma and hematologic malignancies, Honorary Clinical Associate Professor at The University of Melbourne, and Deputy Director of Radiotherapy at Peter MacCallum Cancer Centre. We are joined by Dr. Mario Levis, Assistant Professor in the Department of Oncology from the University of Turin and first author of a paper in this month’s issue, Peri-transplant radiotherapy in refractory or relapsed Hodgkin lymphoma patients undergoing autologous stem cell transplant: long term results of a retrospective study of the Fondazione Italiana Linfomi. Our other guest is Dr. Jennifer Peterson, Associate Professor in the Department of Radiation Oncology at Mayo Clinic Florida, who is the supervising author of another paper this month, Don’t put the CART before the horse: The role of radiation therapy in peri-CAR T-cell therapy for aggressive B-cell non-Hodgkin lymphoma.